|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 29 June 2004
doi: 10.1242/jcs.01222
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Prostate Research Group, Surgical Oncology, Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, UK
2 YCR Cancer Research Unit (Area 13), Department of Biology, University of York, PO BOX 373, York, YO10 5DD, UK
3 Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB2 2QQ, UK
* Author for correspondence (e-mail: ac43{at}york.ac.uk)
Accepted 15 March 2004
Stem cells are clonogenic cells with self-renewal and differentiation properties, which may represent a major target for genetic damage leading to prostate cancer and benign prostatic hyperplasia. Stem cells remain poorly characterised because of the absence of specific molecular markers that permit us to distinguish them from their progeny, the transit amplifying cells, which have a more restricted proliferative potential. Human CD133 antigen, also known as AC133, was recently identified as a haematopoietic stem cell marker. Here we show that a small population (approximately 1%) of human prostate basal cells express the cell surface marker CD133 and are restricted to the 
2ß1hi population, previously shown to be a marker of stem cells in prostate epithelia (Collins, A. T., Habib, F. K., Maitland, N. J. and Neal, D. E. (2001). J. Cell Sci. 114, 3865-3872). 2ß1hi/CD133+ cells exhibit two important attributes of epithelial stem cells: they possess a high in vitro proliferative potential and can reconstitute prostatic-like acini in immunocompromised male nude mice.
Key words: Stem cells, CD133, Integrins, Prostate
This article has been cited by other articles:
|
|
 |
|
  B. Bhatia, M. Jiang, M. Suraneni, L. Patrawala, M. Badeaux, R. Schneider-Broussard, A. S. Multani, C. R. Jeter, T. Calhoun-Davis, L. Hu, et al. Critical and Distinct Roles of p16 and Telomerase in Regulating the Proliferative Life Span of Normal Human Prostate Epithelial Progenitor Cells J. Biol. Chem., October 10, 2008; 283(41): 27957 - 27972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jaksch, J. Munera, R. Bajpai, A. Terskikh, and R. G. Oshima Cell Cycle-Dependent Variation of a CD133 Epitope in Human Embryonic Stem Cell, Colon Cancer, and Melanoma Cell Lines Cancer Res., October 1, 2008; 68(19): 7882 - 7886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Konishi, K. Shimada, M. Nakamura, E. Ishida, I. Ota, N. Tanaka, and K. Fujimoto Function of JunB in Transient Amplifying Cell Senescence and Progression of Human Prostate Cancer Clin. Cancer Res., July 15, 2008; 14(14): 4408 - 4416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Maitland and A. T. Collins Prostate Cancer Stem Cells: A New Target for Therapy J. Clin. Oncol., June 10, 2008; 26(17): 2862 - 2870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Hart and W. S. El-Deiry Invincible, but Not Invisible: Imaging Approaches Toward In Vivo Detection of Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2901 - 2910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Shu, K. K. Wong, J. M. Su, A. M. Adesina, L. T. Yu, Y. T. M. Tsang, B. C. Antalffy, P. Baxter, L. Perlaky, J. Yang, et al. Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma Stem Cells, June 1, 2008; 26(6): 1414 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies Endocr. Rev., April 1, 2008; 29(2): 234 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.E. Schwab, P. Hutchinson, and C.E. Gargett Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells Hum. Reprod., April 1, 2008; 23(4): 934 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Barclay, L. S. Axanova, W. Chen, L. Romero, S. L. Maund, S. Soker, C. J. Lees, and S. D. Cramer Characterization of Adult Prostatic Progenitor/Stem Cells Exhibiting Self-Renewal and Multilineage Differentiation Stem Cells, March 1, 2008; 26(3): 600 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Huttner, P. Janich, M. Kohrmann, J. Jaszai, F. Siebzehnrubl, I. Blumcke, M. Suttorp, M. Gahr, D. Kuhnt, C. Nimsky, et al. The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease Stem Cells, March 1, 2008; 26(3): 698 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ieta, F. Tanaka, N. Haraguchi, Y. Kita, H. Sakashita, K. Mimori, T. Matsumoto, H. Inoue, H. Kuwano, and M. Mori Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 638 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xin, R. U. Lukacs, D. A. Lawson, D. Cheng, and O. N. Witte Self-Renewal and Multilineage Differentiation In Vitro from Murine Prostate Stem Cells Stem Cells, November 1, 2007; 25(11): 2760 - 2769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck, W. Matsui, S. Piccirillo, A. L. Vescovi, F. DiMeco, A. Olivi, et al. Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma Stem Cells, October 1, 2007; 25(10): 2524 - 2533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Patrawala, T. Calhoun-Davis, R. Schneider-Broussard, and D. G. Tang Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+{alpha}2{beta}1+ Cell Population Is Enriched in Tumor-Initiating Cells Cancer Res., July 15, 2007; 67(14): 6796 - 6805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stewart, N. Fleshner, H. Cole, and J. Sweet Comparison of annexin II, p63 and {alpha}-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study J. Clin. Pathol., July 1, 2007; 60(7): 773 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Francis and C. Richardson Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements Genes & Dev., May 1, 2007; 21(9): 1064 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamada, S.-i. Yokoyama, X.-D. Wang, N. Fukuda, and N. Takakura Cardiac Stem Cells in Brown Adipose Tissue Express CD133 and Induce Bone Marrow Nonhematopoietic Cells to Differentiate into Cardiomyocytes Stem Cells, May 1, 2007; 25(5): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I. A. Sesterhenn, D. G. McLeod, S. Srivastava, and J. S. Rhim Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens Cancer Res., April 1, 2007; 67(7): 3153 - 3161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Li, D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsay, M. Wicha, M. F. Clarke, and D. M. Simeone Identification of Pancreatic Cancer Stem Cells Cancer Res., February 1, 2007; 67(3): 1030 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Lawson, L. Xin, R. U. Lukacs, D. Cheng, and O. N. Witte Isolation and functional characterization of murine prostate stem cells PNAS, January 2, 2007; 104(1): 181 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.E. Gargett Uterine stem cells: What is the evidence? Hum. Reprod. Update, January 1, 2007; 13(1): 87 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yoshida, S. Shimmura, N. Nagoshi, K. Fukuda, Y. Matsuzaki, H. Okano, and K. Tsubota Isolation of Multipotent Neural Crest-Derived Stem Cells from the Adult Mouse Cornea Stem Cells, December 1, 2006; 24(12): 2714 - 2722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Singh, A Uzgare, I Litvinov, S R Denmeade, and J T Isaacs Combinatorial androgen receptor targeted therapy for prostate cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 653 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V. Litvinov, D. J. Vander Griend, Y. Xu, L. Antony, S. L. Dalrymple, and J. T. Isaacs Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells. Cancer Res., September 1, 2006; 66(17): 8598 - 8607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sagrinati, G. S. Netti, B. Mazzinghi, E. Lazzeri, F. Liotta, F. Frosali, E. Ronconi, C. Meini, M. Gacci, R. Squecco, et al. Isolation and Characterization of Multipotent Progenitor Cells from the Bowman's Capsule of Adult Human Kidneys J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2443 - 2456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Hall, J. D. Lathia, N. G. A. Miller, M. A. Caldwell, and C. Ffrench-Constant Integrins Are Markers of Human Neural Stem Cells Stem Cells, September 1, 2006; 24(9): 2078 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Heer, A. T. Collins, C. N. Robson, B. K. Shenton, and H. Y. Leung KGF suppresses {alpha}2{beta}1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J. Cell Sci., April 1, 2006; 119(Pt 7): 1416 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wang, A. J. Garcia, M. Wu, D. A. Lawson, O. N. Witte, and H. Wu Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation PNAS, January 31, 2006; 103(5): 1480 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mimeault and S. K. Batra Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies Carcinogenesis, January 1, 2006; 27(1): 1 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland Prospective Identification of Tumorigenic Prostate Cancer Stem Cells Cancer Res., December 1, 2005; 65(23): 10946 - 10951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dalrymple, L. Antony, Y. Xu, A. R. Uzgare, J. T. Arnold, J. Savaugeot, L. J. Sokoll, A. M. De Marzo, and J. T. Isaacs Role of Notch-1 and E-Cadherin in the Differential Response to Calcium in Culturing Normal versus Malignant Prostate Cells Cancer Res., October 15, 2005; 65(20): 9269 - 9279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Marzesco, P. Janich, M. Wilsch-Brauninger, V. Dubreuil, K. Langenfeld, D. Corbeil, and W. B. Huttner Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells J. Cell Sci., July 1, 2005; 118(13): 2849 - 2858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kania, D. Corbeil, J. Fuchs, K. V. Tarasov, P. Blyszczuk, W. B. Huttner, K. R. Boheler, and A. M. Wobus Somatic Stem Cell Marker Prominin-1/CD133 Is Expressed in Embryonic Stem Cell-Derived Progenitors Stem Cells, June 1, 2005; 23(6): 791 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Burger, X. Xiong, S. Coetzee, S. N. Salm, D. Moscatelli, K. Goto, and E. L. Wilson Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue PNAS, May 17, 2005; 102(20): 7180 - 7185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xin, D. A. Lawson, and O. N. Witte The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis PNAS, May 10, 2005; 102(19): 6942 - 6947. [Abstract] [Full Text] [PDF]
|
|
